Understanding the type of arthritis, its causes, and management options is the first step toward living well with the ...
Shares of Esperion Therapeutics fell after the company agreed to acquire Corstasis Therapeutics, the developer of Enbumyst, in a deal valued at up to $255 million. The stock was down 8.1% to $3.01 on ...
CEO Andrew Robbins outlined the company’s transition into a pre-commercial stage at an annual healthcare conference, ...
PHOENIX — The Phoenix Suns' struggles to get their unit fully healthy will continue into the future. According to NBA insider Shams Charania, Suns forward Dillon Brooks sustained a broken left hand ...
Dr Coney and Veeral Sheth, MD, MBA, FACS, FASRS, discuss treatment selection, treatment goals, and unmet needs for patients diagnosed with wet AMD and DME. Dr Sheth discusses his insights on anti-VEGF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results